Central administration of palmitoylethanolamide cuts down hyperalgesia in mice by using inhibition of NF‐κB nuclear signalling in dorsal root ganglia. Eur J Pharmacol All a few research are in line with existing literature on PEA’s substantial therapeutic index, that makes it an interesting prospect for the first line therapy https://griffinsreoy.onzeblog.com/30730903/facts-about-palmitoylethanolamide-revealed